Literature DB >> 7012025

Immediate hypersensitivity to Cryptococcus neoformans.

Y J Tang, R Morelli.   

Abstract

The role of the capsular polysaccharide in anaphylactic reactions to Cryptococcus neoformans was investigated. Groups of mice were sensitized with viable cells of either a moderately encapsulated strain of C. neoformans or a non-encapsulated variant. Anaphylactic reactions were observed in both groups of mice to a similar extent when challenged with whole cells. Mice sensitized with the encapsulated strain and challenged with homologous polysaccharide showed only mild hypersensitivity symptoms. Mice sensitized with either the encapsulated or the nonencapsulated strain showed cross-reactivity when challenged with killed cells of the heterologous strain. These data indicate that the capsular polysaccharide plays a minor role in anaphylactic reactions to C. neoformans and that the sensitizing antigen is probably located in the cell wall of the yeast.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012025      PMCID: PMC351390          DOI: 10.1128/iai.31.2.842-844.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

Review 1.  Cryptococcosis: current status.

Authors:  M L Littman; J E Walter
Journal:  Am J Med       Date:  1968-12       Impact factor: 4.965

2.  Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.

Authors:  T R Kozel; R P Mastroianni
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

3.  Relationship of dermal and pulmonary sensitivity to extracts of Candida albicans.

Authors:  J Kabe; K Aoki; T Ishizaki; T Miyamoto; H Nakazawa; M Tomaru
Journal:  Am Rev Respir Dis       Date:  1971-09

4.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

6.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

7.  Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness.

Authors:  T R Kozel; W F Gulley; J Cazin
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

8.  Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.

Authors:  F Farhi; G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

9.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

10.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.